The Pharmacokinetic Study of WH-1 Ointment in Subjects With Chronic Diabetic Foot Ulcers

Trial Profile

The Pharmacokinetic Study of WH-1 Ointment in Subjects With Chronic Diabetic Foot Ulcers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 03 Feb 2017

At a glance

  • Drugs Centella asiatica/Plectranthus amboinicus (Primary)
  • Indications Diabetic foot ulcer
  • Focus Pharmacokinetics
  • Sponsors Oneness Biotech
  • Most Recent Events

    • 25 Jan 2017 Planned End Date changed from 1 Jun 2016 to 1 Sep 2018.
    • 25 Jan 2017 Planned primary completion date changed from 1 Mar 2016 to 1 Jun 2018.
    • 23 Nov 2015 Planned End Date changed from 1 Dec 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top